<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report a case of pediatric <z:hpo ids='HP_0011009'>acute</z:hpo> non-lymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (ANLL) with <z:mp ids='MP_0004026'>monosomy</z:mp> 7 occurring in a child successfully treated for <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (ALL) nine years earlier </plain></SENT>
<SENT sid="1" pm="."><plain>Acquired <z:mp ids='MP_0004026'>monosomy</z:mp> 7 is currently recognized as a distinct therapy-related cytogenetic abnormality which nonrandomly occurs as a late complication of cytotoxic therapy used in the treatment of both malignant and nonmalignant disease </plain></SENT>
<SENT sid="2" pm="."><plain>Most commonly, this occurs as a <z:e sem="disease" ids="C0005940" disease_type="Disease or Syndrome" abbrv="">disorder of bone</z:e> marrow <z:mp ids='MP_0000002'>morphology</z:mp> and function characterized as a <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) or ANLL </plain></SENT>
<SENT sid="3" pm="."><plain>This case report emphasizes the need for continued evaluation of long-term survivors of <z:e sem="disease" ids="C0278704" disease_type="Neoplastic Process" abbrv="">childhood cancer</z:e> to identify and minimize therapy-related side effects without compromising successful management </plain></SENT>
</text></document>